Indication

Facial lentigo

Facial lentigo refers to a benign, acquired hyperpigmented macule or thin plaque occurring on the integumentary system of the face, most frequently presenting as a solar lentigo secondary to chronic ultraviolet radiation exposure. Read more about Facial lentigo

7 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Facial lentigo therapies.

Showing 1–7 of 7 drugs

TAZAROTENE

ACNE PRODUCTS·PSORIASIS·+5
TARO PHARM USA

TAZAROTENE

ACNE PRODUCTS·PSORIASIS·+5
PACIFIC/GREENST

TAZAROTENE

ACNE PRODUCTS·PSORIASIS·+5
Cosette Pharmaceuticals

TAZAROTENE

ACNE PRODUCTS·PSORIASIS·+5
MIDLOTHIAN LABO

TAZAROTENE

ACNE PRODUCTS·PSORIASIS·+5
TARO/SUN PHARMA
Filter & compare in the drug finder →Opens the drug finder with Facial lentigo preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Facial lentigo.

Facial lentigo refers to a benign, acquired hyperpigmented macule or thin plaque occurring on the integumentary system of the face, most frequently presenting as a solar lentigo secondary to chronic ultraviolet radiation exposure.

It primarily affects older adults and individuals with fair skin types, though it can occur across diverse populations with significant cumulative photoaging or as part of rare genetic syndromes.

Clinically, lesions appear as well-circumscribed, light-to-dark brown, round or irregular macules that persist independently of seasonal sunlight variations.

Pathophysiologically, the condition is defined by localized epidermal hyperplasia with elongation of the rete ridges, marked basal layer hyperpigmentation, and increased melanin production with or without a slight, non-atypical proliferation of basal melanocytes.

Personalize your experience

Follow Facial lentigo and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it